STOCK OPTIONS AND WARRANTS (Details 2) - shares |
9 Months Ended | 12 Months Ended |
---|---|---|
Sep. 30, 2018 |
Dec. 31, 2017 |
|
Exercisable number of options | 557,600 | 396,350 |
Stock Options [Member] | ||
Number of options | 478,850 | |
Weighted average remaining life in years | 8 years 2 months 12 days | 8 years 10 months 21 days |
Exercisable number of options | 396,350 | |
Stock Options [Member] | ||
Number of options | 793,850 | |
Exercisable number of options | 557,600 | |
1.00-2.50 [Member] | ||
Number of options | 330,350 | 330,350 |
Weighted average remaining life in years | 8 years | 9 years 5 months 16 days |
Exercisable number of options | 330,350 | 247,850 |
2.51-5.00 [Member] | ||
Number of options | 35,000 | 35,000 |
Weighted average remaining life in years | 2 years 1 month 6 days | 8 years 6 months 21 days |
Exercisable number of options | 35,000 | 35,000 |
5.10-14.00 [Member] | ||
Number of options | 428,500 | 113,500 |
Weighted average remaining life in years | 8 years 10 months 25 days | 7 years 4 months 2 days |
Exercisable number of options | 192,250 | 113,500 |
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|